Certifications 2

MSDS-No.: 290260
V006.1
LOCTITE SF 7400 known as LOCTITE 7400 20ml Blister M/L
Page 8 of 13
SECTION 10: Stability and reactivity
10.1. Reactivity
Reaction with strong acids.
Reacts with strong oxidants.
10.2. Chemical stability
Stable under recommended storage conditions.
10.3. Possibility of hazardous reactions
See section reactivity
10.4. Conditions to avoid
No decomposition if used according to specifications.
10.5. Incompatible materials
See section reactivity
10.6. Hazardous decomposition products
Irritating organic vapours.
SECTION 11: Toxicological information
11.1. Information on toxicological effects
General toxicological information:
The mixture is classified based on the available hazard information for the ingredients as defined in the classification criteria for
mixtures for each hazard class or differentiation in Annex I to Regulation 1272/2008/EC. Relevant available health/ecological
information for the substances listed under Section 3 is provided in the following.
Oral toxicity:
May cause irritation to the digestive tract.
Inhalative toxicity:
May cause respiratory irritation.
Vapors may cause drowsiness and dizziness.
Skin irritation:
Solvent may remove essential oils from the skin making it susceptible to attack from other chemicals.
Repeated exposure may cause skin dryness or cracking.
Eye irritation:
Causes serious eye irritation.
Acute oral toxicity:
Hazardous components
CAS-No.
Value
type
Value
Route of
application
Exposure
time
Species
Method
n-Butyl acetate
123-86-4
LD50
> 8.800 mg/kg
oral
rat
BASF Test
4-Methylpentan-2-one
108-10-1
LD50
2.080 mg/kg
oral
rat
OECD Guideline 401 (Acute
Oral Toxicity)
Acute inhalative toxicity:
Hazardous components
CAS-No.
Value
type
Value
Route of
application
Exposure
time
Species
Method
n-Butyl acetate
123-86-4
LC50
> 23,4 mg/l
4 h
rat
OECD Guideline 403 (Acute
Inhalation Toxicity)
4-Methylpentan-2-one
108-10-1
Acute
toxicity
estimate
(ATE)
11 mg/l
Vapor.
Expert judgement
4-Methylpentan-2-one
108-10-1
LC50
8,2 - 16,4 mg/l
Vapor.
4 h
rat
OECD Guideline 403 (Acute
Inhalation Toxicity)